Eckert & Ziegler BEBIG

iodine raw material shortage ends for brachytherapy implantation seeds

Seneffe, Belgium, March 20, 2017, Eckert & Ziegler BEBIG announces that the shortage of iodine isotopes for the production of its brachytherapy implantation seeds has been overcome. The company's Uzbek supplier is in a position to resume deliveries.

"We are pleased to announce that the short-term deficiency has now been overcome and that we are looking forward to getting back to normal in the coming weeks." states Dr. Harald Hasselmann, Managing Director of Eckert & Ziegler BEBIG and Member of the Board of Directors of Eckert & Ziegler AG.

During the iodine shortage, Eckert & Ziegler BEBIG had to resort to other suppliers, who extended their capacities as far as possible. Due the company's stock keeping, downtime in the implantation seed production in Berlin, Germany, was avoided. "I would like to thank our customers for their patience and for trusting in our commitment to fulfill their orders under the circumstances" adds Dr. Hasselmann.

---

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Eckert & Ziegler BEBIG via Globenewswire